PORTLAND — Oregon Attorney General Ellen Rosenblum says the state will get nearly $4 million in a multistate settlement with a British drug maker over the diabetes drug Avandia.
Rosenblum said Thursday that GlaxoSmithKline will pay $90 million to 38 states to settle a suit alleging it misrepresented the cardiovascular risks of the drug.
A spokesman, Jeff Manning, says much of the Oregon money will fund the Department of Justice consumer protection operation, and about $400,000 will go to state agencies, such as the Department of Corrections, that bought the drug.
